Shopping Cart
Remove All
Your shopping cart is currently empty
Otilimab (GSK 3196165) is a humanized monoclonal antibody against granulocyt-macrophage colony-stimulating factor (GM-CSF). Otilimab has anti-inflammatory activity, regulates the biological function of GM-CSF by blocking the interaction between GM-CSF and its cell surface receptors, and can be used in studies to treat severe COVID-19 pneumonia.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $122 | - | In Stock | |
| 5 mg | $322 | - | In Stock | |
| 10 mg | $549 | - | In Stock | |
| 25 mg | $873 | - | In Stock | |
| 50 mg | $1,170 | - | In Stock | |
| 100 mg | $1,580 | - | In Stock |
| Description | Otilimab (GSK 3196165) is a humanized monoclonal antibody against granulocyt-macrophage colony-stimulating factor (GM-CSF). Otilimab has anti-inflammatory activity, regulates the biological function of GM-CSF by blocking the interaction between GM-CSF and its cell surface receptors, and can be used in studies to treat severe COVID-19 pneumonia. |
| Synonyms | MOR103, GSK 3196165 |
| Reactivity | Human |
| Verified Activity | Immobilized Human GM-CSF Protein (aa 18-144, His) at 2 μg/mL (30 μL/well) can bind Otilimab. The EC50 is 10.54 ng/mL. |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | CSF2/GM-CSF |
| Molecular Weight | 142.22 kDa |
| Cas No. | 1638332-55-4 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | Human IgG1 lambda2 |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.